Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Get guidance on which passive funds to buy for retirement, focusing on cost, diversification, and long-term goals.
24,385 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
A letter allegedly from Sam Bankman-Fried is under intense scrutiny as prosecutors question its authenticity. Amid fa...
A prominent quadruple amputee cornhole champion has been charged with murder following a fatal confrontation in Maryl...
March’s selling surge has left more than half industry sectors mired in correction territory, prompting fresh bets on...
A fresh, investor-ready look at StoneX's Q2 2026 results. This article breaks down the key numbers, what they mean fo...
A clear, practical look at Expedia's Q1 2026 earnings, what drove results, and what to watch next. Learn the segments...
Investors are asking what's going with Uber stock as the company diversifies beyond ridesharing. This guide breaks do...
Markets react to a surprising Air Force One seat allocation featuring Nvidia’s CEO, sparking chatter that export lice...
Dell Technologies rides a booming AI infrastructure cycle into 2027, with a record AI backlog and ambitious revenue t...
A new energy setback from the Iran conflict is reverberating worldwide. Global flows are disrupted, prices move, and ...
Explore the highlights from the (rlx) 2026 earnings call, including what drove revenue, how margins are shaping up, a...
As the calendar flips to May, many investors rethink risk. This guide shows three cryptocurrencies to unload before s...